Cancer Council Australia joins The Australian Living Evidence Collaboration

The Australian Living Evidence Consortium (ALEC) and members are delighted to announce that Cancer Council Australia has officially become a member of ALEC.  Cancer Council Australia are the 14th member group of ALEC.

The addition of Cancer Council Australia as an ALEC member demonstrates the strong alignment between the vision and goals of Cancer Council Australia to change the way the world creates and uses trustworthy knowledge. This provides the foundation for a strong, mutually beneficial and long-term relationship.

ALEC is a partnership of 14 leading clinical, consumer and research groups (www.livingevidence.org.au). The Consortium is led by Cochrane Australia (based in the School of Public Health and Preventive Medicine at Monash University).

The other Members of the Australian Living Evidence Consortium are:

·       Cochrane Australia

·       Arthritis Australia

·       Australian Diabetes Educators Association 

·       Australian Diabetes Society 

·       Australasian Paediatric Endocrine Group 

·       Diabetes Australia

·       Australian and New Zealand Society of Nephrology 

·       Australia and New Zealand Musculoskeletal Clinical Trials Network 

·       Heart Foundation

·       Kidney Health Australia 

·       CARI Guidelines

·       Cancer Council Australia

·       National COVID-19 Clinical Evidence Taskforce

·       Stroke Foundation